1 | SYN115 | - | - | - | - | 1件: 6 6 |
2 | SYN115 Tablets, 60 mg | - | - | - | - | 1件: 6 6 |
3 | Tozadenant (SYN115) 120 mg BID | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
4 | Tozadenant (SYN115) 180 mg BID | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
5 | Tozadenant (SYN115) 240 mg BID | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
6 | Tozadenant (SYN115) 60 mg BID | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |